About Biofourmis Singapore Pte.
Biofourmis is a global healthcare AI company that delivers clinically validated software-based therapeutics and remote patient monitoring solutions. For physicians, Biofourmis offers an AI-driven platform, notably Biovitals™, which is designed to predict clinical exacerbations and health deterioration days to weeks in advance, thereby aiming to reduce hospital readmissions and enhance patient outcomes. The company’s technology supports a continuum of care, from enabling “Hospital at Home” models and timely discharge to facilitating care in skilled nursing facilities at home, by providing real-time vital signs monitoring and analytics.
Furthermore, Biofourmis partners with health systems, payers, and biopharma companies to revolutionize care delivery and drug development. Its solutions are utilized in managing various complex chronic conditions, including heart failure, acute coronary syndrome, COPD, cancer, and chronic pain. The platform also accelerates drug development through digital biomarkers and supports decentralized and hybrid clinical trials, offering comprehensive technology and services for remote data collection and patient monitoring. While Biofourmis maintains key offices globally, including in Singapore, the legal entity “BIOFOURMIS SINGAPORE PTE. LTD.” was registered as “Gazetted To Be Struck Off” as of April 2026.
Focus Areas
Business Intelligence
| Key Investors | General Atlantic, SoftBank Vision Fund, Intel Capital, CVS Health, Openspace Ventures, MassMutual Ventures, Sequoia Capital, EDBI, Aviva Ventures, SGInnovate, SpesNet Pte, Eden Strategy Institute, Bessemer Venture Partners |
| Partnerships | GE HealthCare, Community Health Network, Nascentia Health, WellSpan Health, Lee Health, Mayo Clinic, Brigham and Women's Hospital, multiple top pharmaceutical companies, AdventHealth |
| Acquisitions | Biovotion, Gaido Health (Takeda Pharmaceuticals' oncology-focused digital therapeutics company), Merged with CopilotIQ |
| Technology | Cloud-based infrastructure, AI-driven algorithms, Biovitals platform, device-agnostic, predictive analytics, machine learning, digital biomarkers, digital clinical trials solution, connected ecosystem, integrates with EMRs (Cerner, Epic) |
| FDA Clearances | 2 cleared products (estimated) |
What Physicians Need to Know
Biofourmis stands out for physicians by enabling early identification of patient deterioration, often weeks in advance, allowing for proactive interventions and potentially preventing hospital re-admissions. Their AI-powered platform provides advanced tools for delivering personalized care and real-time insights into vital signs and symptoms. The system offers software-based therapeutic recommendations and supports comprehensive remote patient management across various acuity levels and conditions. For researchers, their decentralized clinical trial solutions can accelerate drug development and offer more equitable access to treatment options. The user-friendly dashboards, communication interfaces, and interoperability with EMRs, coupled with 24/7/365 clinical and IT support, streamline workflows and enhance care coordination.
Biofourmis' platform is designed for a device-agnostic approach, seamlessly integrating with over 40 different wearable biosensors and digital devices for continuous and episodic monitoring. It also offers interoperability and EMR integration to ensure a cohesive data flow within existing healthcare IT infrastructures.
What the Web Says
Biofourmis Singapore Pte. is a digital health company that utilizes AI-driven solutions and wearable biosensors for remote patient monitoring, aiming to reduce hospital readmissions and improve patient outcomes, particularly for chronic conditions. The company has received generally positive reviews for its mission and product, which is praised for its ability to provide proactive interventions and personalized treatment plans. However, recent news indicates that the former CEO is facing charges related to alleged fraud and falsified invoices.
Overall: MixedStrengths
- Strong company mission and product
- AI-driven platform for proactive interventions and personalized treatment
- Potential to reduce hospital readmissions and improve patient outcomes
- Good work-life balance reported by some employees
- Opportunities for growth and new challenges
- Remote work options and supportive colleagues
Limitations
- Allegations of fraud and falsified invoices against the former CEO
- Some employees report stressful experiences due to toxic executive leadership
- Layoffs occurred without prior notice
- Product team offered constructive feedback, suggesting areas for improvement
- Issues with the patient-facing app, including bugs and login problems
- Compensation may not be competitive compared to other health-tech companies
Based on reviews from: Indeed.com, Comparably, AI tool (aitool.com), Elion, KLAS Research, The Silicon Review, Innovations in Healthcare, LeadIQ, Google Play Store (Biofourmis Care Patient app reviews), Reddit
Last updated: 2026-07-17
Videos
News, demos, and interviews about Biofourmis Singapore Pte..
Videos load interactively. If none appear, search YouTube for Biofourmis Singapore Pte. →
Press & Coverage
Frequently Asked Questions
Comparisons
When choosing between RhythmAnalytics and PMcardio, physicians should consider their primary use case and desired integration. RhythmAnalytics excels in automated, continuous monitoring and interpretation of cardiac arrhythmias from single-lead ECG data. Its cloud-based API deployment makes it ideal for integration into existing systems that handle data from various FDA-cleared ECG devices, such as Holter monitors, […]
Related Companies
Intelligent Voice AI (IVAI) is an agentic AI platform that deploys AI voice agents specifically designed for healthcare, insurance, legal, and home services businesses. For physicians and medical practices, IVAI’s Evolve AI Agents act as an AI workforce, not just an answering service, handling a comprehensive range of administrative and operational tasks. These agents can […]
Dext, formerly known as Receipt Bank, is a company that specializes in bookkeeping automation, leveraging data, technology, and applied AI to enhance productivity and efficiency for businesses, accountants, and bookkeepers. [3, 16] Their platform is designed to streamline financial document management and automate bookkeeping tasks, aiming to simplify the accounting process and enable more informed […]
Cortex (https://www.cortex.app) is an AI-powered internal developer portal designed to enhance engineering excellence and streamline software development workflows. For physicians, this translates to a platform that can indirectly improve healthcare technology by enabling engineering teams to build more reliable, secure, and efficient software. The platform helps in cataloging, scoring, and assigning actions to improve service […]
Nino is an AI-powered financial planning and tax service that aims to provide comprehensive financial guidance. For physicians, Nino’s AI software can help manage income, student loans, and plan career transitions, such as moving from training to practice or considering practice ownership. The platform allows physicians to view loans, income, and savings in one place, […]
Coral AI is a healthcare artificial intelligence company that aims to streamline administrative workflows for healthcare providers, ultimately accelerating patient access to care. The company’s AI-driven platform integrates with existing healthcare systems, including EHRs, fax lines, and payer portals, to automate complex administrative tasks. This includes patient intake, prior authorizations, billing, compliance, and patient outreach. […]
SamaCare is a healthcare AI company that provides a cloud-based workflow intelligence platform designed to streamline the prior authorization process for specialty medications. The company’s platform aims to reduce the administrative burden on medical practices, improve approval rates, and add predictability to patient care. By digitizing the often manual and paper-heavy prior authorization process, SamaCare […]